1. Home
  2. ARCT vs HTBI Comparison

ARCT vs HTBI Comparison

Compare ARCT & HTBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • HTBI
  • Stock Information
  • Founded
  • ARCT 2013
  • HTBI 1926
  • Country
  • ARCT United States
  • HTBI United States
  • Employees
  • ARCT N/A
  • HTBI N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • HTBI Savings Institutions
  • Sector
  • ARCT Health Care
  • HTBI Finance
  • Exchange
  • ARCT Nasdaq
  • HTBI Nasdaq
  • Market Cap
  • ARCT 487.0M
  • HTBI 641.9M
  • IPO Year
  • ARCT N/A
  • HTBI 2012
  • Fundamental
  • Price
  • ARCT $17.65
  • HTBI $37.25
  • Analyst Decision
  • ARCT Strong Buy
  • HTBI Buy
  • Analyst Count
  • ARCT 8
  • HTBI 4
  • Target Price
  • ARCT $61.00
  • HTBI $39.00
  • AVG Volume (30 Days)
  • ARCT 405.9K
  • HTBI 42.1K
  • Earning Date
  • ARCT 03-06-2025
  • HTBI 01-23-2025
  • Dividend Yield
  • ARCT N/A
  • HTBI 1.30%
  • EPS Growth
  • ARCT N/A
  • HTBI N/A
  • EPS
  • ARCT N/A
  • HTBI 3.20
  • Revenue
  • ARCT $160,399,000.00
  • HTBI $193,436,000.00
  • Revenue This Year
  • ARCT $7.33
  • HTBI N/A
  • Revenue Next Year
  • ARCT $4.71
  • HTBI $3.67
  • P/E Ratio
  • ARCT N/A
  • HTBI $11.33
  • Revenue Growth
  • ARCT N/A
  • HTBI 4.69
  • 52 Week Low
  • ARCT $14.30
  • HTBI $23.55
  • 52 Week High
  • ARCT $45.00
  • HTBI $38.99
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 45.85
  • HTBI 61.69
  • Support Level
  • ARCT $15.34
  • HTBI $35.68
  • Resistance Level
  • ARCT $17.95
  • HTBI $38.22
  • Average True Range (ATR)
  • ARCT 1.17
  • HTBI 1.07
  • MACD
  • ARCT -0.08
  • HTBI 0.30
  • Stochastic Oscillator
  • ARCT 39.08
  • HTBI 81.24

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

About HTBI HomeTrust Bancshares Inc.

HomeTrust Bancshares Inc operates as a bank holding company. It engaged in the business of planning, directing and coordinating the business activities of the Bank. The Bank is a North Carolina state chartered bank and provides a range of retail and commercial banking products.

Share on Social Networks: